Naproxen Warning Unjustified, Say FDA Experts
Report Linking Aleve to Heart Attacks Unnecessarily Scared Public
Another expert cautioned that studies presented previously during the
committee's deliberations suggested that other
related to naproxen
"I think we need to accept the fact that all of them have some risk with
regard to [heart attack and stroke] risk," said John T. Farrar, MD, a
senior scholar at the University of Pennsylvania Center for Epidemiology and
Bayer Inc., which makes Aleve, released a statement noting that data it
submitted to the FDA committee showed no evidence of increased heart attack or
stroke risk with the drug when it is taken as directed.
"Bayer believes the evidence presented to the committee and the
subsequent discussions support our confidence that Aleve is safe and effective
for the relief of minor aches and pain," said Erica Peitler, the company's
senior vice president of research and development.
Lyketsos told the committee that ADAPT study leaders will release the
study's results on the safety of naproxen and Celebrex in a medical journal
within the next few weeks.